The ATRIA score is superior to the m-CHA2DS2-Vasc score in predicting in-hospital mortality in COVID-19.
Ozge Ozcan AbaciogluArafat YıldırımPublished in: Revista da Associacao Medica Brasileira (1992) (2021)
In our study, we showed that the anticoagulation and risk factors in atrial fibrillation and m-CHA2DS2-Vasc scores can be used as predictors of thrombosis and mortality in COVID-19 patients. In addition, the predictive value of the anticoagulation and risk factors in atrial fibrillation score was higher than that of m-CHA2DS2-Vasc. The use of the anticoagulation and risk factors in atrial fibrillation score to assess high-risk patients in COVID-19 may be recommended.
Keyphrases
- atrial fibrillation
- risk factors
- oral anticoagulants
- sars cov
- catheter ablation
- left atrial
- left atrial appendage
- coronavirus disease
- direct oral anticoagulants
- heart failure
- end stage renal disease
- percutaneous coronary intervention
- ejection fraction
- newly diagnosed
- chronic kidney disease
- pulmonary embolism
- prognostic factors
- venous thromboembolism
- peritoneal dialysis
- type diabetes
- left ventricular
- respiratory syndrome coronavirus
- coronary artery disease
- cardiovascular disease
- mitral valve